Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:34:11 EDT Mon 16 Jun 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:IZOZF - IZOTROPIC CORPORATION - https://izocorp.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
IZOZF - Qnot subscribed0.22+0.00592.814.6390.20  0.22  0.200.33  0.018615:50:37Jun 1315 min RT 2¢

Recent Trades - All 9 today
Time ETExPriceChangeVolume
15:50:37Q0.220.0059410
15:50:37Q0.21550.0014410
14:30:46Q0.20-0.01411,000
13:46:35Q0.21-0.0041275
13:40:23Q0.2057-0.008428
11:04:30Q0.208-0.00612,500
11:03:21Q0.208-0.00612,500
09:50:51Q0.20-0.01415,000
09:50:45Q0.20-0.01412,500
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-06-13 08:01U:IZOZFNews ReleaseIzotropic Provides Marketing Update
2025-06-10 08:03U:IZOZFNews ReleaseIzotropic Revises License Agreement with The Regents of the University of California
2025-05-16 22:37U:IZOZFNews ReleaseIzotropic's U.S. FDA Regulatory Pathway Greenlit, Company Provides Corporate Update
2025-04-02 15:32U:IZOZFNews ReleaseIzotropic Engages International Communications Consultant, Grants Incentive Stock Options & RSUs to Key Personnel, Amends Promissory Note with Primary Lender
2025-03-25 08:03U:IZOZFNews ReleaseIzotropic Completes Pre-Submission Meeting with FDA for Breast Cancer Screening Indication
2025-03-10 08:01U:IZOZFNews ReleaseIzotropic to Present at Investor Conference March 13th
2025-02-19 08:02U:IZOZFNews ReleaseFDA Sets Meeting Date with Izotropic
2025-02-05 20:34U:IZOZFNews ReleaseIzotropic Reschedules Investor Conference Presentation to March 13th
2025-02-03 08:35U:IZOZFNews ReleaseIzotropic to Present at Investor Conference February 6th
2025-01-29 08:02U:IZOZFNews ReleaseIzotropic Announces Timelines and Milestones to IzoView Product Launch
2025-01-17 08:02U:IZOZFNews ReleaseIzotropic Featured in Announcement of Research and Markets' U.S. Breast Cancer Analysis and Forecast
2025-01-15 08:02U:IZOZFNews ReleaseIzotropic Announces Team Leading Clinical Study Design and FDA Regulatory Submissions
2025-01-09 08:02U:IZOZFNews ReleaseIzotropic Files Pre-Submission with U.S. FDA for Breast Cancer Screening
2024-12-04 14:44U:IZOZFNews ReleaseIzotropic Provides Update on Annual General Meeting Materials and Voting Procedures
2024-08-23 09:02U:IZOZFNews ReleaseIzotropic Announces Regulatory Approval Plans to Launch Izoview for Breast Cancer Diagnostics in Patients with Dense Breasts in the U.S. and EU